CN102397532B - Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof - Google Patents
Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof Download PDFInfo
- Publication number
- CN102397532B CN102397532B CN2011103626456A CN201110362645A CN102397532B CN 102397532 B CN102397532 B CN 102397532B CN 2011103626456 A CN2011103626456 A CN 2011103626456A CN 201110362645 A CN201110362645 A CN 201110362645A CN 102397532 B CN102397532 B CN 102397532B
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- preparation
- interferon
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 241000241413 Propolis Species 0.000 title claims abstract description 16
- 150000001875 compounds Chemical class 0.000 title claims abstract description 16
- 229940069949 propolis Drugs 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 201000010099 disease Diseases 0.000 title abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 10
- 241001503699 Muscovy duck parvovirus Species 0.000 title abstract 3
- 102000014150 Interferons Human genes 0.000 claims abstract description 18
- 108010050904 Interferons Proteins 0.000 claims abstract description 18
- 229940079322 interferon Drugs 0.000 claims abstract description 18
- 241000272525 Anas platyrhynchos Species 0.000 claims abstract description 11
- 241000746375 Andrographis Species 0.000 claims abstract description 11
- 235000016993 Agrimonia Nutrition 0.000 claims abstract description 6
- 241000206469 Pulsatilla Species 0.000 claims abstract description 6
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 6
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract 2
- 241000272834 Cairina moschata Species 0.000 claims description 22
- 239000003292 glue Substances 0.000 claims description 11
- 239000009806 pulsatillae Substances 0.000 claims description 5
- 244000173853 Sanguisorba officinalis Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000005303 weighing Methods 0.000 abstract 2
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 241001092084 Agrimonia Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000581682 Sanguisorba Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 239000003640 drug residue Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound propolis composition for treating the muscovy duck parvovirus disease and a preparation method thereof, relating to the field of animal medicaments. The preparation method of the composition comprises the following steps of: (1) performing ultrafine smashing on various components (except interferon) in a formula respectively, and sieving with a 700-mesh sieve; (2) weighing 15-35 parts by weight of propolis, 5-20 parts by weight of interferon for duck, 10-30 parts by weight of common andrographis herb and 15-30 parts by weight of coptis root, and mixing for 5-10 minutes to uniform state; (3) weighing 10-40 parts by weight of Chinese pulsatilla root, 10-35 parts by weight of garden burnet root, 15-45 parts by weight of indigowoad leaf and 10-40 parts by weight of hairyvein agrimonia herb and bud, and mixing for 5-10 minutes to uniform state; and (4) combining the compositions obtained in the steps (2) and (3), and continually mixing for 10-15 minutes to uniform state to obtain the compound propolis composition. The preparation method has the beneficial effects of reasonable formula and easiness for preparing; the compound propolis composition has the advantages of no toxic or side effect, environmental friendliness, no medicament residue, no medicament tolerance, ultrafine smashing, high bioavailability and very remarkable effect; and as proved by clinical application, the compound propolis composition has a special treatment effect on the muscovy duck parvovirus disease.
Description
Technical field
The present invention relates to the animal field of medicaments, particularly a kind of compound bee-glue composition that is specifically designed to the treatment muscovy duckling parvovirosis and preparation method thereof.
Background technology
Muscovy duckling parvovirosis is a kind of acute, the septic infectious disease that is caused by muscovy duckling parvovirosis virus, and main manifestations is that the serious inflammation of intestinal, intestinal mucosa necrosis come off, the swollen pus of intestinal tube is hemorrhage.This disease has infectiousness and the mortality rate of height, mainly betides for 3 ages in week with interior young Muscovy duck, and case fatality rate has a strong impact on the growth of Muscovy duck between 22%-43%.This disease all can occur throughout the year, is one of principal disease of the foster duck industry of harm.
The pathogen of primary disease is muscovy duckling parvovirosis virus, and virus resistance to external world is very strong.It is national that this disease almost spreads all over all poultry of the world, is widely distributed.At present, prevent and treat this disease the most frequently used be anti virus herb and Western medicine, Chinese medicine is unreasonable or simple pulverizing the just due to its prescription, particle diameter is excessive, drug release is slower, causes its bioavailability lower, clinical effectiveness is not fine; And various antiviral drugs such as the Ministry of Agriculture such as ribavirin, amantadine ban use of.
Therefore researching and developing a kind of drug residue free of muscovy duckling parvovirosis, the generation that has no drug resistance, the significant specific medicament of clinical effectiveness for the treatment of is one of this field scientific research technical staff new problem anxious to be resolved.
Summary of the invention
The object of the invention is to overcome above-mentioned weak point, provide that a kind of reasonable recipe, preparation are simple, micronizing, bioavailability are high, successful, have no drug resistance and the compound bee-glue composition of effective treatment muscovy duckling parvovirosis of drug residue and preparation method thereof.
For achieving the above object, implementation of the present invention is as follows: a kind of compound bee-glue composition for the treatment of muscovy duckling parvovirosis, by following component by weight mixed preparing form: propolis 15-35 part, duck are with interferon 5-20 part, Herba Andrographis 10-30 part, Rhizoma Coptidis 15-36 part, Radix Pulsatillae 10-40 part, Radix Sanguisorbae 10-35 part, Folium Isatidis 15-45 part, Herba Agrimoniae 10-40 part.
Described various component optimum ratio amount is: 25 parts of propolis, 10 parts of interferon of duck, 20 parts of Herba Andrographis, 20 parts of Rhizoma Coptidis, 25 parts of the Radix Pulsatillaes, 25 parts of Radix Sanguisorbaes, 35 parts of Folium Isatidiss, 30 parts of Herba Agrimoniaes.
A kind of preparation method for the treatment of the compound bee-glue composition of muscovy duckling parvovirosis, carry out as follows:
(1) the various compositions (except interferon) in prescription are crossed 700 mesh sieves after micronizing respectively;
(2) take by weight propolis 15-35 part, duck with interferon 5-20 part, Herba Andrographis 10-30 part, Rhizoma Coptidis 15-30 part, mix 5-10 minute to even;
(3) take by weight Radix Pulsatillae 10-40 part, Radix Sanguisorbae 10-35 part, Folium Isatidis 15-45 part, Herba Agrimoniae 10-40 part, mix 5-10 minute to even;
(4) merge the compositions that above-mentioned (2), (3) step make, continue to mix 10-15 minute to even.
The medicinal property of each component is as follows:
Propolis: bitter, hot, cold, return spleen, stomach warp, have the function of anti-inflammation, antalgesic-antipruritic, promotion tissue regeneration, raising immunity, antiallergic oxidation, hemostasis, protection gastrointestinal mucosa.
Interferon: be a kind of broad-spectrum disease resistance toxic agent, RNA and DNA viruses are had inhibition or killing action; Can inducing apoptosis of tumour cell, thus killing off tumor cells; Interferon all has immunological enhancement to humoral immunization, cellular immunization, macrophage and NK cell.
Herba Andrographis: bitter, cold, GUIXIN, lung, bladder, large intestine channel have the function of heat-clearing and toxic substances removing, reducing swelling and alleviating pain; Cure mainly cold, fever, damp-heat diarrhea, carbuncle sore furunculosis etc.
Rhizoma Coptidis: bitter, cold, return liver, the heart, spleen, stomach, gallbladder, large intestine channel, have the function of heat clearing and damp drying, eliminating fire and detoxication; Cure mainly damp-heat dysentery, hyperactivity of heart-fire, excessiveness of stomach-fire, dampness-heat in the liver and gallbladder, conjunctival congestion and swelling pain, fire-toxin carbuncle sore etc.
The Radix Pulsatillae: bitter, cold, return stomach, large intestine channel, have the function of heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery; Cure mainly toxic-heat and blood stasis, damp and hot removing heat from blood etc.
Radix Sanguisorbae: sour, bitter, puckery, be slightly cold, return liver, large intestine channel, have the function of removing pathogenic heat from blood and toxic substance from the body, arresting bleeding and healing up ulcer; Cure mainly dysentery, epistaxis, metrorrhagia, the yellow furunculosis of skin ulcer etc.
Folium Isatidis: bitter, cold, GUIXIN, stomach warp have the function of heat-clearing and toxic substances removing, blood cooling and ecchymoses removing; Cure mainly calentura and send out speckle, laryngopharynx swelling and pain, hematodiarrhoea, jaundice, carbuncle, erysipelas etc.
Herba Agrimoniae: bitter, puckery, flat, GUIXIN, Liver Channel have the function of astringing to arrest bleeding, dysentery relieving, detoxifcation; Cure mainly have blood in stool, hematuria, haematemesis, epistaxis, dysentery, carbuncle sore tumefacting virus etc.
Above all flavor Chinese medicine for pathogenic microorganism and clinical symptoms and the pathological change of muscovy duckling parvovirosis, is brought into play the effect for the treatment of both the principal and secondary aspects of a disease according to the Chinese medical theory compatible combination.
The invention has the beneficial effects as follows: reasonable recipe, preparation is simple, and substep mixes more even; Chinese medicine composition is pollution-free, no drug residue, have no drug resistance, and cost is low, draws materials wide, and micronizing, bioavailability are high, can also can drink water by spice, and the curative effect highly significant.The present invention is according to Chinese veterinarian's traditional theory, optimize this seven flavors Chinese medicine, and make them form pure Chinese powder medicine according to optimum ratio, clinical practice proves, the treatment muscovy duckling parvovirosis there is specially good effect, and make its product meat reach nuisanceless requirement, satisfy the export standard of product, guaranteed that effectively people's is healthy.
The specific embodiment
Below in conjunction with preferred embodiment, to details are as follows according to the specific embodiment provided by the invention:
Embodiment 1
A kind of compound bee-glue composition for the treatment of muscovy duckling parvovirosis and preparation method thereof: carry out as follows: (every part by 10g)
(1) the various compositions (except interferon) in prescription are crossed 700 mesh sieves after micronizing respectively;
(2) take by weight 150 parts of propolis, duck with 50 parts of interferon, 100 parts of Herba Andrographis, 150 parts of Rhizoma Coptidis, mix 5-10 minute to even;
(3) take by weight 100 parts of the Radix Pulsatillaes, 100 parts of Radix Sanguisorbaes, 150 parts of Folium Isatidiss, 100 parts of Herba Agrimoniaes, mix 5-10 minute to even;
(4) merge the compositions that above-mentioned (2), (3) step make, continue to mix 10-15 minute to even.
Embodiment 2
A kind of compound bee-glue composition for the treatment of muscovy duckling parvovirosis and preparation method thereof: carry out as follows: (every part by 10g)
(1) the various compositions (except interferon) in prescription are crossed 700 mesh sieves after micronizing respectively;
(2) take by weight 250 parts of propolis, duck with 100 parts of interferon, 200 parts of Herba Andrographis, 200 parts of Rhizoma Coptidis, mix 5-10 minute to even;
(3) take by weight 250 parts of the Radix Pulsatillaes, 200 parts of Radix Sanguisorbaes, 300 parts of Folium Isatidiss, 250 parts of Herba Agrimoniaes, mix 5-10 minute to even;
(4) merge the compositions that above-mentioned (2), (3) step make, continue to mix 10-15 minute to even.
Embodiment 3
A kind of compound bee-glue composition for the treatment of muscovy duckling parvovirosis and preparation method thereof: carry out as follows: (every part by 10g)
(1) the various compositions (except interferon) in prescription are crossed 700 mesh sieves after micronizing respectively;
(2) take by weight 350 parts of propolis, duck with 00 part of interferon alpha-2,300 parts of Herba Andrographis, 300 parts of Rhizoma Coptidis, mix 5-10 minute to even;
(3) take by weight 400 parts of the Radix Pulsatillaes, 350 parts of Radix Sanguisorbaes, 450 parts of Folium Isatidiss, 400 parts of Herba Agrimoniaes, mix 5-10 minute to even;
(4) merge the compositions that above-mentioned (2), (3) step make, continue to mix 10-15 minute to even.
Clinical trial:
With the ill poultry of product feeding of the present invention etc., a day dose is: by the every 100g of the present invention, spice 120kg feeds, and drinking-water 220kg, is used in conjunction 3-5 day at every day 2-3 time; Reach the purpose for the treatment of disease after oral by gastrointestinal absorption.
Table is the field applicable cases contrast of the present invention and other medicines treatment muscovy duckling parvovirosis:
| Numbering | Group | Case fatality rate % | Cure rate % | Symptom rate % is arranged during end |
| I | The blank group | 29.2 | 32.9 | 37.9 |
| II | The loose group of muscovy duckling parvovirosis | 12.4 | 70.0 | 17.6 |
| III | Present composition group | 8.6 | 81.8 | 9.6 |
This clinical effectiveness statistical analysis, present composition treatment group is being compared difference extremely significantly (P＜0.01) with the loose group of muscovy duckling parvovirosis aspect cure rate.
Above-mentioned detailed description of compound bee-glue composition of this treatment muscovy duckling parvovirosis and preparation method thereof being carried out with reference to embodiment; illustrative rather than determinate; can list several embodiment according to institute's limited range; therefore in the variation and the modification that do not break away under general plotting of the present invention, within should belonging to protection scope of the present invention.
Claims (2)
1. compound bee-glue composition for the treatment of muscovy duckling parvovirosis, it is characterized in that by following component by weight mixed preparing form: propolis 15-35 part, duck are with interferon 5-20 part, Herba Andrographis 10-30 part, Rhizoma Coptidis 15-30 part, Radix Pulsatillae 10-40 part, Radix Sanguisorbae 10-35 part, Folium Isatidis 15-45 part, Herba Agrimoniae 10-40 part, and the preparation method of described compositions is carried out as follows:
(1) the various compositions except interferon in prescription are crossed 700 mesh sieves after micronizing respectively;
(2) take by weight and get propolis 15-35 part, duck with interferon 5-20 part, Herba Andrographis 10-30 part, Rhizoma Coptidis 15-30 part, mixes 5-10 minute to even;
(3) take by weight Radix Pulsatillae 10-40 part, Radix Sanguisorbae 10-35 part, Folium Isatidis 15-45 part, Herba Agrimoniae 10-40 part, mix 5-10 minute to even;
(4) merge the compositions that above-mentioned (2), (3) step make, continue to mix 10-15 minute to even.
2. the compound bee-glue composition for the treatment of muscovy duckling parvovirosis according to claim 1, is characterized in that described various component optimum ratio amount is: 25 parts of propolis, 10 parts of interferon of duck, 20 parts of Herba Andrographis, 20 parts of Rhizoma Coptidis, 25 parts of the Radix Pulsatillaes, 25 parts of Radix Sanguisorbaes, 35 parts of Folium Isatidiss, 30 parts of Herba Agrimoniaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103626456A CN102397532B (en) | 2011-11-16 | 2011-11-16 | Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103626456A CN102397532B (en) | 2011-11-16 | 2011-11-16 | Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102397532A CN102397532A (en) | 2012-04-04 |
| CN102397532B true CN102397532B (en) | 2013-05-22 |
Family
ID=45880430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103626456A Expired - Fee Related CN102397532B (en) | 2011-11-16 | 2011-11-16 | Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102397532B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104758865A (en) * | 2015-03-10 | 2015-07-08 | 格特生物制药（天津）有限公司 | Traditional Chinese medicine composition for treating parvovirus diseases of cairna moschata and preparation method thereof |
| PL3747445T3 (en) * | 2018-01-31 | 2024-04-08 | Sichuan Inlu Weite Pharmaceutical Technology Co., Ltd. | Pulsatilla saponin b4 for use in the treatment of dairy cow mastitis |
| CN110269880A (en) * | 2019-07-26 | 2019-09-24 | 烟台海研制药有限公司 | A kind of clear particle of wormwood artemisia indigo plant epidemic disease, preparation method and application |
| NL2032218B1 (en) * | 2022-06-20 | 2023-02-24 | Inst Of Animal Husbandry And Veterinary Medicine Jiangxi Academy Of Agricultural Sciences | A Chinese medicinal preparation for preventing and treating duck virus disease, and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362059A (en) * | 2001-01-05 | 2002-08-07 | 唐山王清任制药有限公司 | Nano Chinese medicine piece and its prepn |
| CN101411762A (en) * | 2007-10-19 | 2009-04-22 | 天津生机集团有限公司 | Chinese medicinal composition for treating Canine parvovirus disease and preparation thereof |
-
2011
- 2011-11-16 CN CN2011103626456A patent/CN102397532B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362059A (en) * | 2001-01-05 | 2002-08-07 | 唐山王清任制药有限公司 | Nano Chinese medicine piece and its prepn |
| CN101411762A (en) * | 2007-10-19 | 2009-04-22 | 天津生机集团有限公司 | Chinese medicinal composition for treating Canine parvovirus disease and preparation thereof |
Non-Patent Citations (2)
| Title |
|---|
| 当前规模化养鸭场常见疾病的诊断及防止新技术;沈志强;《水禽世界》;20060630;17-23 * |
| 沈志强.当前规模化养鸭场常见疾病的诊断及防止新技术.《水禽世界》.2006,17-23. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102397532A (en) | 2012-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102397532B (en) | Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof | |
| CN102600457B (en) | Compound propolis composition used for treating pig viral diarrhea and preparation method thereof | |
| CN102600305A (en) | Compound propolis composition for treating swine pasteurellosis and preparation method for same | |
| CN102319288B (en) | Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof | |
| CN102488746B (en) | Compound propolis composition for treating swine infectious atrophic rhinitis and preparation method thereof | |
| CN102370971B (en) | Compound bee glue composition for treating fowl pox and preparation method thereof | |
| CN102283889B (en) | Pure Chinese medicinal composition for treating duck virus hepatitis and preparation method thereof | |
| CN102430113B (en) | Compound propolis composition for treating porcine pseudorabies and preparation method thereof | |
| CN102335416B (en) | Compound Chinese medicinal composition for treating hog cholera and preparation method thereof | |
| CN102397528B (en) | Compound propolis composition for treating chicken infectious anemia and preparation method thereof | |
| CN102488881B (en) | Compound propolis composition for promoting pig growth and fattening as well as its preparation method | |
| CN102397533B (en) | Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof | |
| CN102670863B (en) | Compound propolis composition for treating acariasis of domestic animal and preparation method thereof | |
| CN103585407B (en) | Chinese medicine composition for the treatment of pig infectious atrophic rhinitis and preparation method thereof | |
| CN102600259B (en) | Complex propolis composition for treating eperythrozoon suis and preparation method thereof | |
| CN102397531B (en) | Compound propolis composition for treating duck plague and preparation method thereof | |
| CN102397529B (en) | Compound propolis composition for treating chicken reticuloendotheliosis and preparation method thereof | |
| CN102397473B (en) | Composite propolis composition for treating gosling plague and preparation method thereof | |
| CN102670804A (en) | Compound propolis composition for treating poultry dysentery and preparation method thereof | |
| CN102397530B (en) | Compound propolis composition for treating avian infectious encephalomyelitis and preparation method thereof | |
| CN102397383B (en) | Compound propolis pure Chinese medicinal composition for treating avian spirochaetosis and preparation method thereof | |
| CN102430098B (en) | Compound propolis composition for treating swine streptococcicosis and preparation method thereof | |
| CN102370970B (en) | Traditional Chinese medicine compound composition for treating blue ear disease of sows and preparation method thereof | |
| CN102370969B (en) | Compound Chinese medicine composition for treating piglet blue ear disease and preparation method thereof | |
| CN102370739B (en) | Compound propolis composition for treating whitecomb of chickens and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130522 Termination date: 20151116 |
|
| EXPY | Termination of patent right or utility model |